Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Conditions
Interventions
Aripiprazole
Locations
33
United States
Dothan, Alabama, United States
Goodyear, Arizona, United States
Orange, California, United States
Sacramento, California, United States
Wildomar, California, United States
Norwich, Connecticut, United States
Start Date
January 1, 2013
Primary Completion Date
August 1, 2014
Completion Date
September 1, 2014
Last Updated
October 16, 2015
NCT07455929
NCT06740383
NCT07460453
NCT07445984
NCT07395206
NCT07010614
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions